Full-Time

Accountant

Posted on 10/31/2025

CooperSurgical

CooperSurgical

1,001-5,000 employees

Provides reproductive health products and services

Compensation Overview

$58.5k - $78k/yr

+ Starting base pay between 58578? wait exact values: 58,478 to 77,970 per year. Use 58478 and 77970 + The actual base pay includes many factors and is subject to change and modification in the future. This position may also be eligible for other types of compensation and benefits.

Canandaigua, NY, USA

In Person

Category
Accounting (3)
, ,
Required Skills
Financial analysis
Oracle
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in accounting or finance required
  • 2-4 years in an accounting or finance role
  • Experience with ERP systems; Oracle experience preferred, (eBS and HFM) is a plus
  • Highly organized with the ability to manage multiple tasks in a collaborative environment
  • Strong communication and interpersonal skills, with the ability to interact effectively across all levels
  • Experience with monthly close and financial reporting processes
  • Demonstrated understanding of internal controls, analytical thinking, and problem-solving
  • Advanced proficiency in Microsoft Excel
  • Solid understanding of US Generally Accepted Accounting Principles (GAAP)
Responsibilities
  • Perform monthly financial close activities, including journal entries, account reconciliations, intercompany transactions, variance analysis, and data uploads for consolidated reporting.
  • Apply independent judgment to assess the reasonableness of account balances and ensure transactions are properly supported. Recommend or initiate corrective actions as needed.
  • Prepare routine and ad-hoc reports for leadership, sales, and other departments.
  • Ensure timely and accurate financial reporting across the organization.
  • Maintain compliance with US GAAP and internal policies and procedures.
  • Support broader initiatives through ad-hoc reporting and presentations as directed.
  • Compile, review, verify, and analyze large volumes of financial data, demonstrating awareness of relevant financial statement assertions.
  • Collaborate cross-functionally and with external professionals to support business processes and strategic initiatives.

What CooperSurgical does: CooperSurgical develops and provides products, technologies, and services that support women’s, babies’, and families’ health around the world. How its products work: The company offers a range of reproductive health solutions, including contraception, fertility support, and preventive and therapeutic gynecological care. These products assist clinicians and patients through devices, tests, and therapies designed to aid choice and care in reproductive health. How it differs from competitors: CooperSurgical focuses on a broad set of reproductive health needs—covering contraception, fertility, and gynecologic care—trusted by clinicians worldwide for a wide range of tools and services, which can enable more integrated care compared to providers focused on a narrower segment. Goal: To empower individuals and healthcare professionals to make informed health and life choices and improve care for women, babies, and families globally.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Trumbull, Connecticut

Founded

1990

Simplify Jobs

Simplify's Take

What believers are saying

  • Direct sales model strengthens customer relationships and improves data access in mature European markets.
  • Granata Bio investment positions CooperSurgical to capture emerging reproductive health biopharma innovations.
  • obp Surgical acquisition expands specialty surgery portfolio beyond women's health into adjacent surgical markets.

What critics are saying

  • Massachusetts lab quality control scandal triggers regulatory investigations into IVF product testing procedures.
  • European direct sales rollout faces reimbursement denials in France and Germany, limiting adoption.
  • obp Surgical integration stalls due to single-use retractor technology misalignment with existing portfolio.

What makes CooperSurgical unique

  • Direct-to-provider sales model in France, Italy, Germany, Spain eliminates distributor margins.
  • Integrated portfolio spans fertility, labor/delivery, and specialty surgery via obp and Zymōt acquisitions.
  • Proprietary sperm separation technology and single-hand IUD inserter reduce procedural complexity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Parental Leave

Fertility Treatment Support

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Company News

CooperSurgical
Feb 12th, 2026
CooperSurgical to Launch Direct Sales Model for Labor and Delivery Portfolio in Key European Markets

CooperSurgical to launch direct sales model for Labor and Delivery portfolio in key european markets. TRUMBULL, CT, December 11, 2025, CooperSurgical(R), a leader in women's healthcare and fertility solutions, today announced a strategic shift to a direct sales model for its premier Labor and Delivery products in France, Italy, Germany, and Spain. This transition will forge a closer relationship with healthcare providers, reinforcing the company's commitment to advancing the standard of care for women and babies. Beginning in the company's fiscal first quarter, healthcare providers and healthcare facilities in these markets will gain the ability to procure products directly from CooperSurgical. The portfolio includes the vacuum-assisted delivery products, Fetal Pillow(TM) cephalic elevation device, the INSORB(R) subcuticular skin stapler, and the Lone Star(R) retractor system. This change from a distributor-led model is designed to streamline the customer's ordering process, facilitate easier access to these critical technologies, and provide direct support from CooperSurgical's dedicated customer care center. By creating a direct channel, CooperSurgical aims to better support the clinical community, ensuring that physicians have the resources and guidance needed to implement these innovative solutions effectively. This initiative is central to the company's mission of delivering technologies that support healthier families. About CooperSurgical CooperSurgical is a leading company dedicated to advancing the health of women, babies, and families. The company's portfolio offers effective solutions that support clinical efficiency from conception to delivery. With a history of innovation in the fertility and women's health field, CooperSurgical has pioneered new technologies and continues to drive progress in the industry. Existing Customers - Order directly from CooperSurgical Previously purchased through a distributor? CooperSurgical, Inc. has simplified the process. Its dedicated sales team can assist with product availability, pricing, ordering, and delivery information specific to your country

PR Newswire
Mar 10th, 2025
2025 Inception Fertility Physician Summit Brings Together Thought Leaders, Researchers, And Clinicians From Across The Company To Celebrate Patient Dedication, Collaborate On Research, And Discuss The Future Of Fertility Care

North America's largest provider of fertility services collaborates, celebrates achievements in fertility care including unparalleled patient services. HOUSTON, March 10, 2025 /PRNewswire/ -- Inception Fertility™ (Inception), North America's largest provider of comprehensive fertility services, held its Annual Inception Physician Summit in Nashville, Tennessee, February 22-25, 2024. The Summit brings together team members, including reproductive specialists and clinical managers, from across Inception's vast network of global fertility clinics, The Prelude Network®, to share best practices and resources that make each clinic a leading fertility provider in their respective markets

FinSMEs
Jan 15th, 2025
Granata Bio Secures $15M Series A+ Funding

Granata Bio Corporation, a biopharma company in Boston, MA, raised $15 million in Series A+ funding. Investors included Gedeon Richter, CooperSurgical, and Amboy Street Ventures. The funds will support the company's pipeline and exploration of new assets in reproductive health. Granata Bio has raised over $30 million to date.

Daily Journal
Oct 9th, 2024
Toxic embryo culture lawsuits allowed to proceed

Four plaintiffs have filed separate lawsuits against CooperSurgical Inc., accusing the company of selling defective embryo culture which caused embryos to die.

Medical Device Network
Sep 4th, 2024
CooperSurgical introduces single-hand inserter for Paragard IUD

CooperSurgical has introduced a new single-hand inserter for the Paragard copper intrauterine device (IUD).

INACTIVE